China's new FIL, coupled with other factors including the U.S. China trade conflict, and ambitious long-term strategies such as "Made in China 2025", means potentially greater investment opportunities for German companies - particularly in high-tech manufacturing, life sciences and healthcare, and engineering, where Germany excels.